Interleukin-6 induces prostate cancer cell growth accompanied by activation of Stat3 signaling pathway

Abstract

IL-6 is an autocrine growth factor for LNCaP human prostate cancer cells; the effects of IL-6 on prostate cancer cell growth are mediated through the Janus kinase-signal transducers and activators of transcription (JAK-STAT) signaling pathway.